The North America Brain Monitoring Market is witnessing robust growth fueled by advancements in neurotechnology, increased prevalence of neurological disorders, and significant investments by key industry players. The market was valued at USD 2,893.0 Million in 2025 and is projected to reach USD 7,247.9 Million by 2035, growing at a CAGR of 8.7% from 2024 to 2035.
The economic impact of tariffs on "North America Brain Monitoring Market".
Market Growth Drivers
Rising Prevalence of Neurological Disorders: The growing incidence of neurological conditions such as epilepsy, Alzheimer’s disease, stroke, and Parkinson’s disease across North America is a key market driver. As per the Centers for Disease Control and Prevention (CDC), millions are diagnosed every year with disorders impacting brain health. This has led to increased demand for diagnostic and monitoring devices. Companies like Medtronic plc, which offers advanced EEG and MEG solutions, are expanding their product portfolios to address this rising need.
Advancements in Brain Monitoring Technologies: Major technological breakthroughs such as wireless and minimally invasive brain monitoring devices are transforming the market. These advancements improve patient comfort, enable remote monitoring, and drive adoption across hospitals and ambulatory care centers. For example, Natus Medical Incorporated launched next-generation portable EEG devices providing real-time data transfer and cloud access, further accelerating market growth.
Market Trends
Integration of Artificial Intelligence: With the emergence of artificial intelligence (AI) and machine learning, brain monitoring systems are becoming more sophisticated. AI-driven software can analyze complex brain data faster, offering accurate diagnostics and predictive analytics. For instance, companies like Cerebras Systems and GE Healthcare are leveraging AI to enhance brain scan interpretations, facilitate timely interventions, and improve outcomes.
Adoption of Wearable Brain Monitoring Devices: There is a notable trend toward the adoption of wearable and portable brain monitoring solutions. Such devices enable continuous monitoring outside clinical settings, supporting home-based patient management. Philips, for example, has introduced lightweight, user-friendly EEG headbands for sleep study and ongoing neurological monitoring, which increases patient engagement and compliance.
Market Opportunity
Expansion into Untapped Rural Healthcare Markets: Significant opportunities exist to extend brain monitoring technologies to rural and under-served regions in North America, aided by telehealth and mobile solutions. Companies like Medtronic and Natus Medical are actively pursuing collaborations with remote care providers.
Development of Pediatric and Geriatric-Focused Devices: Tailoring brain monitoring solutions to pediatric and geriatric populations represents untapped potential, considering the unique neurological care needs in these age groups. Specialized programs and devices are being explored by organizations such as Nihon Kohden.
North America Brain Monitoring Market Revenue (USD Million), 2020-2035
The chart illustrates a strong upward trajectory in market revenue for North America Brain Monitoring from 2020 to 2035. The market begins with USD 1,560.0 Million in 2020, reflecting steady growth. Notable accelerations are observed as revenues reach USD 2,893.0 Million in 2025—driven by increased adoption of advanced monitoring technologies and rising neurological cases. Continued innovation and healthcare investments push the revenue growth higher, culminating at USD 7,247.9 Million by 2035. Overall, the CAGR of 8.7% demonstrates the sector's promising outlook, underpinned by ongoing R&D, supportive government policies, and expanding applications in clinical and home care settings.
North America Brain Monitoring Market by Region, 2025
The 2025 market share pie chart emphasizes the regional distribution within North America. The United States holds the dominant position with 78% of the share, underlining its advanced healthcare infrastructure, high adoption of neurotech, and strong presence of industry leaders. Canada secures 16%, benefiting from increased healthcare investments and regional expansion of key players. Mexico captures 4% due to growing awareness and gradual adoption, while Other Latin America and Caribbean regions together account for 2%, reflecting emerging market potential. The visualization highlights the US’s central role and points to growth opportunities in other NAFTA and regional zones as healthcare access expands.
Recent Developments in North America Brain Monitoring Market
In May 2024, Medtronic plc announced its collaboration with Mayo Clinic to accelerate the development of AI-powered neurodiagnostic tools for brain injury monitoring. The partnership aims for rapid enhancement of EEG analytics for real-time traumatic brain injury (TBI) management, leveraging Mayo Clinic’s patient data and Medtronic’s integrated monitoring devices.
In March 2024, Natus Medical Incorporated launched its advanced mobile EEG headset, the Natus NeuroLink, designed for both clinical environments and remote patient monitoring. Featuring cloud connectivity and streamlined patient interface, the device supports rapid diagnosis of epilepsy and other acute neurological events, and is now being adopted in several leading US neurology centers.
In April 2024, Philips introduced a new software platform integrating brain health monitoring with personalized telemedicine. The cloud-based solution utilizes AI algorithms to provide neurologists and caregivers with continuous analytics for Alzheimer’s and dementia patients, aiming to improve prognostic accuracy and patient quality of life across North American care facilities.
Press Releases